287 related articles for article (PubMed ID: 8199575)
1. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Cancelas JA; Lopez J; Cabezudo E; Navas E; Garcia Laraña J; Jimenez Mena M; Diz P; Perez de Oteyza J; Villalon L; Sanchez-Sousa A
Bone Marrow Transplant; 1994 Mar; 13(3):333-4. PubMed ID: 8199575
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Zahid MA; Klotz SA; Hinthorn DR
Chest; 1994 May; 105(5):1597-8. PubMed ID: 8181369
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
5. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
6. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
7. A case report of Candida parapsilosis endocarditis.
Inoue Y; Yozu R; Ueda T; Kawada S
J Heart Valve Dis; 1998 Mar; 7(2):240-2. PubMed ID: 9587869
[TBL] [Abstract][Full Text] [Related]
8. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
[TBL] [Abstract][Full Text] [Related]
10. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
11. [Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Hernández-Torres A; García-Vázquez E; Laso-Ortiz A; Herrero-Martínez JA; Gómez-Gómez J
Rev Esp Quimioter; 2013 Mar; 26(1):51-5. PubMed ID: 23546464
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for breakthrough candidemia.
Nucci M; Colombo AL
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):209-11. PubMed ID: 11957023
[TBL] [Abstract][Full Text] [Related]
13. Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
Jones JM; Sarsam MA; Clarke MA; Hedderwick SA
J Infect; 2002 Apr; 44(3):196-8. PubMed ID: 12099751
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Solomkin JS
New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
17. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Krcméry V; Spánik S; Grausová S; Trupl J; Krupová I; Roidová A; Sálek T; Sufliarsky J; Mardiak J
Neoplasma; 1998; 45(5):336-42. PubMed ID: 9921924
[TBL] [Abstract][Full Text] [Related]
18. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
19. [Amphotericin B resistant severe hepato-splenic candidiasis, responding to fluconazole, in a patient following bone marrow transplantation].
Jakab K; Kelemen E; Váradi G; Török I
Orv Hetil; 1991 Mar; 132(12):643-5. PubMed ID: 2011389
[TBL] [Abstract][Full Text] [Related]
20. Successful peritransplant therapy in children with active hepatosplenic candidiasis.
Katayama K; Koizumi S; Yamagami M; Tamaru Y; Ichihara T; Konishi M; Maekawa S; Seki H; Taniguchi N
Int J Hematol; 1994 Feb; 59(2):125-30. PubMed ID: 8018905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]